Document 0900 DOCN M9620900 TI Cytotoxic T lymphocytes specific for the synthetic VEINCTR peptide, a sequence found within the Fas molecule and env gp120 in the blood of HIV-1 seropositive individuals. DT 9602 AU Moukrim Z; Achour A; Laboratoire de Physiologie Cellulaire, Universite Pierre et; Marie Curie, Paris, France. SO Cell Mol Biol (Noisy-le-grand). 1995 May;41(3):439-44. Unique Identifier : AIDSLINE MED/96059406 AB We have previously identified a VEINCTR peptide common to both the Fasmolecule and HIV-1 gp120. Here we report the characterization in PBMCs from HIV-1-infected individuals of a CD8+ class I restricted CTL activity directed towards this peptide. The peptide is highly conserved in various HIV-1 strains, being located at amino acid 287-293 (VEINCTR), within an epitope known as cell T epitope on the env protein of human immunodeficiency virus type-1. Cell cultures were obtained by polyclonal activation using autologous blast cells and CTL lines generated from frozen peripheral blood lymphocytes of HIV-1 seropositive donors by stimulation with the peptide and recombinant interleukin-2. The env-specific CTL turned out to kill autologous target cells infected with a recombinant vaccinia virus containing the env gene of HIV-1 or pulsed with peptide. Specificity was determined using shorter peptides. The CTL activity was directed against autologous target cells presenting the heptapeptide which is site located in the Fas molecule, known to be functionally involved in T-cell apoptosis. DE Acquired Immunodeficiency Syndrome/*IMMUNOLOGY Amino Acid Sequence Antigens, CD95/GENETICS/*IMMUNOLOGY Apoptosis B-Lymphocytes/IMMUNOLOGY/VIROLOGY Cell Line, Transformed Cytotoxicity Tests, Immunologic Epitopes/*IMMUNOLOGY Human HIV Envelope Protein gp120/GENETICS/*IMMUNOLOGY HLA-A2 Antigen/IMMUNOLOGY Leukocytes, Mononuclear/IMMUNOLOGY Lymphocyte Transformation Molecular Sequence Data Oligopeptides/*IMMUNOLOGY Peptide Fragments/IMMUNOLOGY Support, Non-U.S. Gov't T-Lymphocytes, Cytotoxic/*IMMUNOLOGY Vaccinia Virus/IMMUNOLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).